Correlation Between Papaya Growth and Mink Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Papaya Growth and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Papaya Growth and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Papaya Growth Opportunity and Mink Therapeutics, you can compare the effects of market volatilities on Papaya Growth and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Papaya Growth with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Papaya Growth and Mink Therapeutics.

Diversification Opportunities for Papaya Growth and Mink Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Papaya and Mink is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Papaya Growth Opportunity and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Papaya Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Papaya Growth Opportunity are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Papaya Growth i.e., Papaya Growth and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Papaya Growth and Mink Therapeutics

Assuming the 90 days horizon Papaya Growth Opportunity is not expected to generate positive returns. However, Papaya Growth Opportunity is 4.32 times less risky than Mink Therapeutics. It waists most of its returns potential to compensate for thr risk taken. Mink Therapeutics is generating about -0.08 per unit of risk. If you would invest  1,120  in Papaya Growth Opportunity on August 31, 2024 and sell it today you would lose (1.00) from holding Papaya Growth Opportunity or give up 0.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Papaya Growth Opportunity  vs.  Mink Therapeutics

 Performance 
       Timeline  
Papaya Growth Opportunity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Papaya Growth Opportunity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Papaya Growth is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Papaya Growth and Mink Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Papaya Growth and Mink Therapeutics

The main advantage of trading using opposite Papaya Growth and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Papaya Growth position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.
The idea behind Papaya Growth Opportunity and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets